Rankings
▼
Calendar
AMLX FY 2019 Earnings — Amylyx Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
AMLX
Amylyx Pharmaceuticals, Inc.
$1B
FY 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$1M
Gross Profit
-$10M
-734.4% margin
Operating Income
-$14M
-950.5% margin
Net Income
-$15M
-1039.0% margin
EPS (Diluted)
$-0.26
Cash Flow
Operating Cash Flow
-$11M
Free Cash Flow
-$11M
Stock-Based Comp.
$108,000
Balance Sheet
Total Assets
$3M
Total Liabilities
$29M
Stockholders' Equity
-$25M
Cash & Equivalents
$3M
← FY 2020
All Quarters
